A new generation of ultra-high-cost therapies is reshaping benefits plan risk, while the arrival of generic glucagon-like peptide-1 receptor agonist medications is set to shift one of the largest drug categories, according to Telus Health’s annual drug report. The report found weight-management climbed six positions to rank No. 11 among all drug categories. The category […]
“Eczema is like a rollercoaster; it’s characterized by flares and remissions and flares and remissions — and the cruelest thing is that it’s unpredictable and the flares come at the absolute worst time,” said Dr. Maxwell Sauder, a dermatologist at the Toronto Dermatology Centre, in a session supported by Galderma during Benefits Canada’s 2026 Chronic […]